Article
Recent developments in high-throughput mutation screening.
Pharmacogenomics - 1 Nov 2001
Larsen L A, Christiansen M, Vuust J, Andersen P S
Abstract excerpt
Screening of large sample materials for the presence of known or unknown mutations is a key element in pharmacogenomics. Although automated DNA sequencing has developed rapidly during the last decade, the technology is not well suited for projects involving analysis of hundreds of thousands of mutations. Consequently, a number of methods for high-throughput mutation screening have been developed. DNA microarrays...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
